Yes, I'm happy to indicate that the consultation, as you indicate, is nearly finished, but it is a consultation. Because there is evidence that some over-the-counter medication does not represent good value, either in terms of value for money or efficacy, as well. So, I think it's quite right and proper to review that information and then to come up with new guidance.

There is always, though, the reality that the individual prescriber, whoever they are, has an individual responsibility to make an appropriate prescribing choice for the individual person in front of them. Now, I recognise some of the concerns the company has raised and that you've repeated here. They're concerns that I'm alive to, but I'd be more than happy to make sure that this Chamber is updated on the outcome of the consultation and on any new guidance that I may choose to endorse.FootnoteLink